Germany · Delayed Price · Currency is EUR Springer Nature AG & Co. KGaA Earnings Call Transcripts
Fiscal Year 2026
-
Underlying revenue grew 6% and AOP 8% in H1 2026, led by the research segment and strong open access performance. Updated guidance expects ~6% revenue growth and margin improvement for the year, with robust cash flow and reduced leverage.
-
Q1 2026 saw 6% underlying revenue and 9% AOP growth, led by research and open access. Free cash flow rose to EUR 204 million, leverage dropped to 1.5x, and full-year guidance is reiterated. AI tools and new journal launches support continued outperformance.
Fiscal Year 2025
-
Delivered strong 2025 results with 6% underlying revenue and 9% AOP growth, led by research and open access. 2026 guidance targets 5%-6% revenue growth and further margin expansion, supported by high renewal rates, robust submissions, and ongoing AI-driven efficiencies.
-
Strong nine-month results driven by research and open access growth, with revenue up 5.9% and AOP up 9.9%. Cash flow and leverage improved, supporting confidence in 2025 guidance despite education headwinds and FX impacts.
-
Strong H1 2025 results with 6% underlying revenue and 10% adjusted operating profit growth led to upgraded full-year guidance. Research segment outperformed the market, especially in open access, and significant progress was made in AI and digital initiatives.
-
Q1 2025 saw 6% underlying revenue and 11% AOP growth, led by the research segment and strong open access momentum. Full-year guidance was raised to the upper half of revenue and profit ranges, with margin expansion expected. Cash flow and leverage improved, and AI initiatives advanced.
Fiscal Year 2024
-
Delivered strong 2024 results with 5% revenue and 7% profit growth, led by research and open access expansion. 2025 guidance anticipates continued growth, margin expansion, and stable cash flow, with risks from FX and U.S. funding seen as limited short-term.